Hydroxyurea granules for the management of sickle cell disease in children
Background: Many studies have demonstrated the effectiveness of hydroxyurea in the management of sickle cell disease. The drug, which is an antimetabolite initially developed for the treatment of myeloproliferative disorders has been repurposed, even though its use for the initial indication has bee...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Scientific African |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227622001788 |